Foster Innovation and Collaboration at the 10th Annual Pre-Filled Syringes and Injectable Drug Devices West Coast Conference!
Join us in June 2026 as our renowned West Coast event returns, bringing together biotech pioneers, pharma leaders, and device innovators to shape the future of injectable drug delivery.
This year's conference will bring a brand NEW focus day followed by the two-day main conference offering an unparalleled platform to explore cutting-edge advances in combination product technology while fostering collaboration between pharma, device developers, and regulators.
What You'll Gain:
- Actionable insights to strengthen your drug-device portfolio.
- Opportunities to network with key players shaping the injectable drug delivery landscape.
- A future-focused perspective on innovation, regulation, and patient-centric care.
This must-attend event is your chance to stay ahead in the rapidly evolving injectable drug delivery space. We look forward to welcoming you to the West Coast in June 2026!
2025 Speakers Included
- Alasdair Young, Senior Director - Device Engineering, Gilead Sciences
- Albana Thorpe, Director, Technical Services, Suttons Creek
- Amin Sedighiamiri, Director, Device Development, AstraZeneca
- Angela Muriset, Director, Human Factors Center of Excellence - Combination Product Development, AbbVie
- Aniket Badkar, Director, Pharmaceutical Product Development, Vir Biotechnology
- Antonina Maxey, Senior Engineer, AbbVie
- Bernie Huyghe, Chief Technology Officer, Candid Therapeutics
- Casey Dean, Senior Manager, Device and Packaging Development, Tolmar Inc
- Christina Rabolli, Principal Engineer, Device Development, Bristol Myers Squibb
- Chuck Ventura, Chief Executive Officer, Ventura Solutions
- Daphne King, Previously Associate Director, Regulatory CMC, Biomarin
- Desiree Daniels, Principal Specialist, CMC Management and Regulatory Compliance, Boehringer Ingelheim
- EJ Brandreth, Senior VP, Quality, Inovio
- Greg Salamone, Principal Human Factors Engineer, Regeneron Pharmaceuticals Inc
- James P. Wabby, Executive Director, Head of Regulatory Strategy, emerging Technologies and Combination Products, AbbVie
- John Merhige, CEO, Credence MedSystems, Inc.
- Kevin Zen, Senior Director, IGM Biosciences
- Mitch Zhao, Distinguished Engineer, JnJ Innovative Medicine
- Monica Swinney, Sr. Director, New Product Planning & Drug Delivery Innovation, Gilead Sciences
- Phil Estepa, Executive Director, Pharmaceutical Development, Ionis Pharmaceuticals
- Pratik Mishra, Principal Device Engineer, EdgeOne Medical
- Renato Ravanello, Sr. Director, Device and Packaging Development, Genentech
- Sep Mohseni, Director of Sales Operations, StreriTek
- Sheldon Moberg, Senior VP Drug Delivery, Bexson Biomedical
- Shiang Gwee, Director, Drug Product Development, Altrubio, Inc.
- Speaker, To be confirmed, Crux Product Design Ltd
- Steve Badelt, Executive Vice President and Managing Partner, Suttons Creek
- Sujit K. Basu, Vice President & Head, Ionis
- Thomas Massarany, Sr. Business Development Specialist - Life Science, Zeon Specialty Material Inc
- Tina Rees, Associate Director, Human Factors, Regeneron Pharmaceuticals
- Vince Masciopinto, Customer Solutions Director, SHL Medical
- Wenjing Wang, Associate Principal Scientist in Regulatory Affairs, Merck & Co
- Yasuaki Yoshimura, Research Manager, Mitsubishi Gas Chemical Company, Inc
- Yitian Xiao, Technical and Scientific Expert, Datwyler Pharma Packaging
The full agenda is not yet available for this event.
Follow this event to receive an alert when the agenda becomes available.
Venue
The venue is not yet available for this event.
Follow this event to be informed when the venue is available and stay informed on other changes.
